Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial (Q36725446)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 September 2011
edit
Language Label Description Also known as
English
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
scientific article published on 29 September 2011

    Statements

    Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial (English)
    Amrita Krishnan
    Marcelo C Pasquini
    Brent Logan
    David H Vesole
    Edwin Alyea
    Raymond Comenzo
    Stacey Goodman
    Parameswaran Hari
    Muzaffar H Qazilbash
    Scott Rowley
    Firoozeh Sahebi
    George Somlo
    Dan T Vogl
    Daniel Weisdorf
    Marian Ewell
    Juan Wu
    Nancy L Geller
    Mary M Horowitz
    Blood Marrow Transplant Clinical Trials Network (BMT CTN)
    29 September 2011
    1195-1203

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit